Prevalence of plasmid-mediated quinolone resistance determinants among oxyiminocephalosporin-resistant Enterobacteriaceae in Argentina

Memorias do Instituto Oswaldo Cruz

Volumn 108, Issue 7, 2013, Pages 924-927

  Cruz, Giovanna Rincon ^a,d   Radice, Marcela ^a   Sennati, Samantha ^b   Pallecchi, Lucia ^b   Rossolini, Gian María ^b   Gutkind, Gabriel ^a   Di Conza, Jose Alejandro ^a,c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

^d UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

Author keywords

ESBL producing enterobacteriaceae; Fluoroquinolone; PMQR

Indexed keywords

ANTIINFECTIVE AGENT; ESCHERICHIA COLI PROTEIN; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARGENTINA; CLASSIFICATION; DRUG EFFECTS; ENTEROBACTERIACEAE; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; PREVALENCE;

ANTI-BACTERIAL AGENTS; ARGENTINA; CEPHALOSPORIN RESISTANCE; ENTEROBACTERIACEAE; ESCHERICHIA COLI PROTEINS; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; QUINOLONES;

EID: 84886912469     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/0074-0276130084     Document Type: Article

References (19)

1. Andres P, Lucero C, Soler-Bistué A, Guerriero L, Albornoz E, Tran T, Zorreguieta A, PMQR-Group, Galas M, Corso A, Tolmasky M, Petroni A 2013. Differential distribution of plasmid mediated quinolone resistance genes in clinical enterobacteria with unusual phenotypes of quinolone susceptibility from Argentina. Antimicrob Agents Chemother 57: 2467-2475.
2. Canton R, Coque TM 2006. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 9: 466-475.
3. Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P 2007. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 60: 394-397.
4. Cavaco LM, Hasman H, Xia S, Aarestrup FM 2009. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother 53: 603-608.
5. Clermont O, Bonacorsi S, Bingen E 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66: 4555-4558.
6. CLSI/NCCLS - Clinical and Laboratory Standard Institute/National Committee for Clinical Laboratory Standards 2010. Performance standards for antimicrobial disk susceptibility tests. Supplement M02-A10. Informational Supplement, CLSI, Wayne, 153 pp.
7. Cremet L, Caroff N, Dauvergne S, Reynaud A, Lepelletier D, Corvec S 2011. Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital. Pathol Biol (Paris) 59: 151-156.
8. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 43: 4178-4182.
9. Drlica K, Zhao X 1997. DNA gyrase, topoisomerase IV and the 4-quinolones. Microbiol Mol Biol Rev 61: 377-392.
10. Garcia-Fulgueiras V, Bado I, Mota M, Robino L, Cordeiro N, Varela A, Algorta G, Gutkind G, Ayala J, Vignoli R 2011. Extendedspectrum β-lactamases and plasmid-mediated quinolone resistance in enterobacterial clinical isolates in the paediatric hospital of Uruguay. J Antimicrob Chemother 66: 1725-1729.
11. Jacoby GA, Gacharna N, Black TA, Miller GH, Hooper DC 2009. Temporal appearance of plasmid-mediated quinolone resistance genes. Antimicrob Agents Chemother 53: 1665-1666.
12. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC 2006. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacinmodifying enzyme. Antimicrob Agents Chemother 50: 3953-3955.
13. Quiroga M, Andres P, Petroni A, Soler-Bistué A, Guerriero L, Vargas L, Zorreguieta A, Tokumoto M, Quiroga C, Tolmasky M, Galas M, Centron D 2007. Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina. Antimicrob Agents Chemother 51: 4466-4470.
14. Rodriguez-Martinez JM, Cano ME, Velasco C, Martinez-Martinez L, Pascual A 2011. Plasmid-mediated quinolone resistance: an update. J Infect Chemother 17: 149-182.
15. Sennati S, Santella G, Di Conza J, Pallecchi L, Pino M, Ghiglione B, Rossolini G, Radice M, Gutkind G 2012. Changing epidemiology of extended-spectrum β-lactamases in Argentina: emergence of CTX-M-15. Antimicrob Agents Chemother 56: 6003-6005.
16. Silva-Sanchez J, Barrios H, Reyna-Flores F, Bello-Diaz M, Sanchez-Perez A, Rojas T, Bacterial Resistance Consortium, Garza-Ramos U 2011. Prevalence and characterization of plasmid-mediated quinolone resistance genes in extended-spectrum β-lactamaseproducing Enterobacteriaceae isolates in Mexico. Microb Drug Resist 17: 497-505.
17. Walsh F, Rogers TR 2012. Comparison of plasmid-mediated quinolone resistance and extended-spectrum β-lactamases in thirdgeneration cephalosporin-resistant Enterobacteriaceae from four Irish hospitals. J Med Microbiol 61: 142-147.
18. Wang M, Guo Q, Xu X, Wang X, Ye X, Wu S, Hooper D 2009. New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis. Antimicrob Agents Chemother 53: 1892-1897.
19. Woodford N, Turton JF, Livermore DM 2011. Multiresistant Gramnegative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 35: 736-755.